27 Jan 2026
Over the past few months, JaxBio has begun implementing the HemaChip platform at partner medical centres in Europe and Israel. This phase represents an important transition from clinical validation to use within real-world laboratory workflows.
Participating centres received complete implementation kits, including microarray chips, reagents, and standardised operating protocols, enabling smooth integration into existing diagnostic routines. JaxBio’s team is working closely with clinical and laboratory staff, providing training, remote support, and on-site guidance to ensure consistent sample handling, processing, and data generation across sites.
Initial feedback from participating laboratories indicates that the workflow is straightforward and compatible with routine laboratory practices. The platform enables efficient sample processing and generates clear molecular patterns that support downstream clinical interpretation.
This implementation phase is a key milestone toward broader clinical adoption. It enables the generation of real-world performance data and supports the preparation for subsequent regulatory and translational steps of the HemaChip platform.